Nosopharm raises €2.4 million ($2.6M) to develop a novel antibiotic class

Nosopharm raises €2.4 million ($2.6M) to develop a novel antibiotic class

Lyon, France, March 28, 2017 – Nosopharm, a biotechnology company specialized in the research and development of new antimicrobial molecules,…